Authors:
Bavelier, D
Brozinsky, C
Tomann, A
Mitchell, T
Neville, H
Liu, GY
Citation: D. Bavelier et al., Impact of early deafness and early exposure to sign language on the cerebral organization for motion processing, J NEUROSC, 21(22), 2001, pp. 8931-8942
Authors:
Miller, RG
Moore, DH
Gelinas, DF
Dronsky, V
Mendoza, M
Barohn, RJ
Bryan, W
Ravits, J
Yuen, E
Neville, H
Ringel, S
Bromberg, M
Petajan, J
Amato, AA
Jackson, C
Johnson, W
Mandler, R
Bosch, P
Smith, B
Graves, M
Ross, M
Sorenson, EJ
Kelkar, P
Parry, G
Olney, R
Citation: Rg. Miller et al., Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis, NEUROLOGY, 56(7), 2001, pp. 843-848
Authors:
Kasarskis, EJ
Shefner, JM
Miller, R
Smith, RA
Licht, J
Mitsumoto, H
Hopkins, LC
Rosenfeld, J
Pascuzzi, R
Cornblath, DR
Armon, C
Strong, MJ
Kula, R
Windebank, A
Bosch, EP
Smith, BE
Cashman, N
Sivak, M
Sergay, S
Siddique, T
Sufit, RL
Johnston, W
Brooke, MB
Graves, MC
Olney, RK
Roos, RP
Neville, H
Ringel, SP
Ross, M
Bradley, WG
Sharma, KR
Parry, G
Mandler, R
Giuliani, M
Thornton, CA
Jackson, C
Bryan, W
Bromberg, M
Tandan, R
Fries, T
Phillips, L
Brooks, BR
Fenichel, G
Pestronk, A
Bear, M
Beatey, R
Fuller, C
Hill, R
Malta, E
Nakanishi, A
Patel, A
Thurmond, B
Cedarbaum, JM
Stambler, N
Citation: Ej. Kasarskis et al., A controlled trial of recombinant methionyl human BDNF in ALS, NEUROLOGY, 52(7), 1999, pp. 1427-1433